{
  "id": "https://doi.org/10.21417/B77G6V",
  "type": "dats",
  "attributes": {
    "identifiers": [{
      "identifier": "doi:10.21417/B77G6V",
      "identifier-source": "DataCite"
    }],
    "title": "Ibrutinib therapy increases T cell repertoire diversity in patients with chronic lymphocytic leukemia Shared Project",
    "types": [{"information": {"value": {
      "id": "dataset",
      "title": "Dataset",
      "updated_at": "2016-09-21T00:00:00Z"
    }}}],
    "creators": [{
      "first-name": null,
      "last-name": null
    }],
    "dates": [
      {
        "date": "2016",
        "type": {
          "ontology-term-iri": "http://schema.datacite.org/meta/kernel-3.1/metadata.xsd",
          "value": "publicationYear"
        }
      },
      {
        "date": "2016-10-06T20:18:56Z",
        "type": {
          "ontology-term-iri": "http://schema.datacite.org/meta/kernel-3.1/metadata.xsd",
          "value": "Issued"
        }
      },
      {
        "date": "2016-10-06T20:18:56Z",
        "type": {
          "ontology-term-iri": "http://schema.datacite.org/meta/kernel-3.1/metadata.xsd",
          "value": "Updated"
        }
      }
    ],
    "container-title": "Adaptive Biotechnologies",
    "description": null
  }
}
